Steffen Pietzke

Steffen Pietzke, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Enovix Corp and PDL Biopharma, Inc. We count 31 filings; the first trade dates from 26 January 2016 and the latest from 6 July 2023.

No open-market sale appears; the market trades are 1 purchase worth €251k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 30 share grants.

Most recently, on 7 July 2023, the filings show a share grant worth €23k in Enovix Corp. The clock since the last published purchase (12 August 2021) now reads 1,893 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.